News Pulmonx Corporation

Equities

LUNG

US7458481014

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
7.5 ^USD	+3.02%		+1.35%	-41.18%

Apr. 02	Pulmonx Appoints Mehul Joshi as Chief Financial Officer	MT
Apr. 02	Pulmonx Corporation Announces Chief Financial Officer Changes, Effective April 3, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024	Apr. 10	GL
Pulmonx Appoints Mehul Joshi as Chief Financial Officer	Apr. 02	MT
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer	Apr. 02	GL
Pulmonx Corporation Announces Chief Financial Officer Changes, Effective April 3, 2024	Apr. 02	CI
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	Mar. 15	GL
Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial	Feb. 27	AQ
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial	Feb. 26	BU
Pulmonx Corporation Announces Treatment of the First Patient with the Aeriseal System in Convert II Pivotal Trial	Feb. 26	CI
North American Morning Briefing : Traders Await -2-	Feb. 26	DJ
Pulmonx Shares Fall After Wells Fargo Downgrade	Feb. 23	MT
Wells Fargo Downgrades Pulmonx to Equalweight From Overweight, Cuts Price Target to $14 From $16	Feb. 23	MT
Canaccord Genuity Adjusts Pulmonx's Price Target to $16 From $12, Keeps Buy Rating	Feb. 22	MT
Stifel Adjusts Pulmonx's Price Target to $17 From $15, Keeps Buy Rating	Feb. 22	MT
Wells Fargo Adjusts Pulmonx's Price Target to $16 From $15, Keeps Overweight Rating	Feb. 22	MT
Citigroup Adjusts Pulmonx's Price Target to $17 From $16, Keeps Buy Rating	Feb. 22	MT
Craig-Hallum Adjusts Pulmonx's Price Target to $20 From $18, Keeps Buy Rating	Feb. 22	MT
Transcript : Pulmonx Corporation, Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
Earnings Flash (LUNG) PULMONX CORPORATION Reports Q4 Revenue $19.3M, vs. Street Est of $18.2M	Feb. 21	MT
Pulmonx Corporation Provides Earnings Guidance for the Full Year 2024	Feb. 21	CI
Pulmonx Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pulmonx Corporation

Equities

LUNG

US7458481014

Summary

Filters